-
Global/EN
- Global
- North America
- Latin America
During our French communication of June 14 to our customers in France with regards to the regulatory news relating to the new European authorization of Hy-D®, a wording error was made in the last paragraph and we would like to correct this error.. In that communication, it was mistakenly mentioned that the European Commission had banned "the simultaneous use of 25-hydroxycholecalciferol and calcitriol (1,25(OH)2D3) from Solanum glaucophyllum". Indeed, the regulation in question does not refer to Solanum glaucophyllum itself, but explicitly to the extract of Solanum glaucophyllum.
The correct wording should have been: Note that the European Commission specifies in the conditions of application that the simultaneous use of Hy-D® with glycosylated 1,25 dihydroxycholecalciferol from Solanum glaucophylum extract is not authorized.
Source Official Journal
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.
www.dsm-firmenich.com
15 July 2024
Get in touch with a dsm-firmenich Animal Nutrition & Health specialist or find contacts around the world to suit your needs.
At dsm-firmenich, we love to connect with you.
Follow us on any of the channels below.
We detected that you are visitng this page from United States. Therefore we are redirecting you to the localized version.
